QNCX Quince Therapeutics, Inc.
Healthcare$1.20+9.09%ClosedMarket Cap: $6.7M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Rating Distribution
0 Strong Buy0 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-01-30 | D. Boral Capital | downgrade | Hold | Buy |
| 2026-01-30 | Citizens | downgrade | Market Perform | Market Outperform |
| 2026-01-29 | D. Boral Capital | maintain | Buy | Buy |
| 2025-12-15 | D. Boral Capital | maintain | Buy | Buy |
| 2025-11-13 | D. Boral Capital | maintain | Buy | Buy |
| 2025-09-26 | D. Boral Capital | maintain | Buy | Buy |
| 2025-08-15 | D. Boral Capital | maintain | Buy | Buy |
| 2025-08-12 | JMP Securities | maintain | Market Outperform | Market Outperform |
| 2025-06-13 | D. Boral Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.68 | $0.00 | 2 |
| Fri Dec 31 | $-0.80 | $17.1M | 1 |
| Sun Dec 31 | $-0.80 | $292.4M | 2 |
| Mon Dec 31 | $-0.80 | $486.3M | 1 |